Location
United States, North America
Cheque size
$500K - $5M
Investment Stage
Seed
Series A
Focus Areas
AI
Health IT
Health & Hospital Services
BioTech
Hardware
Deep Tech
Medical Devices
About Investor
Keith Crandell is Co-founder and Managing Director at ARCH Venture Partners. He focuses on life science therapeutics, tools, devices and diagnostics, along with specialty materials, electronics, instrumentation, and photonics, and ARCH is a seed and early-stage investor in technology companies. Before founding ARCH, he worked at Hercules, and at ARCH he has played key roles in the formation and initial funding of companies including 908 Devices, Twist Bioscience, Quanterix, Arbor Biotechnologies, and Vizgen.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.